echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > The Chinese Union of Scientists Research reveals the immunological characteristics of neo-coronary pneumonia

    The Chinese Union of Scientists Research reveals the immunological characteristics of neo-coronary pneumonia

    • Last Update: 2021-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Understanding and understanding the pathogenesis of neo-crown pneumonia is of great significance to its diagnosis and treatment and prevention and control.
    the research alliance, which was spontaneously organized by Chinese scientists, revealed the existence of new infection mechanisms and the characteristics of the body's immune response at different stages of disease onset by establishing large queue data of single-cell transcription group of new coronary pneumonia.
    published online in Cell, an internationally renowned academic journal.
    the wide application of single-cell transcription group sequencing technology in various fields of life science has given birth to many important biological discoveries.
    , however, the application of this technique in the study of new coronary pneumonia has problems such as high cost, small sample size, statistical effectiveness and insufficient universality of conclusions.
    In order to solve the above-mentioned problems, more than 40 hospitals, universities and research institutions in more than 10 provinces and cities in China spontaneously formed the "New Coronary Pneumonia Single Cell Research China Alliance" in May 2020 to jointly establish a large queue of large data in the single-cell transcription group of New Coronary Pneumonia.
    alliance obtained single-cell transcription group sequencing data from 284 samples of nearly 1.5 million cells from 196 new crown patients, and quickly completed the integration and analysis of the data. the
    study found that, in addition to the traditionally thought respiratory endocysts, new coronavirus nucleic acid sequences have been detected in a variety of immune cells, suggesting that the virus has been active in these immune cells transcription and replication, that is, immune cells can not be ruled out as the new coronavirus host cells.
    may be an important feature of the new coronavirus different from the SARS virus, or it may be the cause of the new coronavirus has a strong infectious power.
    this finding is consistent with a strong interferon response in neocytovirus nucleic acid-positive cells and has been confirmed by tissue slicing and staining of the new coronavirus S protein.
    note that the new coronavirus subject ACE2 is barely expressed in immune cells, suggesting that the new coronavirus may have potential new subjects to infect host cells.
    Cheng Tao, director of the Hematology Hospital (Hematology Institute) of the Chinese Academy of Medical Sciences, which participated in the study, said that the results of the study provide new understanding and clues to reveal the pathogenesis and immune characteristics of neocytosis, and are of great significance for finding intervention targets and treatment measures for neocytosis from the perspective of immune cells.
    The member units of the "China Alliance for single-celled research of new crown pneumonia" include Peking University, Naval Medical University, Guangzhou Biological Island Laboratory, Shenzhen Bay Laboratory, Beijing You'an Hospital affiliated with Capital Medical University, China University of Science and Technology, Shenzhen Third People's Hospital, Harbin University of Technology, Institute of Biophysics of the Chinese Academy of Sciences, Zhongshan University, Chinese Academy of Medical Sciences Hematology Hospital (Hematology Research Institute), Army Military Medical University, etc.
    Wen Jinghua Source: Xinhua News Agency Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Metz Medical and may not be reproduced by any media, website or individual without authorization, and shall be reproduced with the words "Source: Mes Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.